Estimated Revenue: $1M to $10M
Funding Status: IPO
Headquarters: London, England, United Kingdom
Total Funding: $310.5M
Investors Number: 24
Number Of Exists: Series C
Founded Date: 2015
Technology: Others
Industry: Gene Therapy
Last Funding Type: Series C
Investor Type: Company
Investment Stage: N/A
Employee Number: 51-100